Expression of cytochrome P450 (CYP) enzymes in human nonpigmented ciliary epithelial cells: Induction of CYP1B1 expression by TCDD

Volotinen M., Mäenpää J., Kankuri E., Oksala O., Pelkonen O., Nakajima M., Yokoi T., Hakkola J.

2009
Investigative Ophthalmology and Visual Science

View publication

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Institute of Biomedicine, Institute of Pharmacology, University of Helsinki, Helsinki, Finland; Santen Oy, Tampere, Finland; Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland; Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan

Related Publications

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.

View all Glaucoma publications